Conclusion:
Only 62% of COVID-19 patients with self-reported olfactory dysfunction
have anosmia or hyposmia on objective psychophysical olfactory
evaluation. Interestingly, the majority of those with confirmed
objective olfactory dysfunction did not have nasal inflammatory
symptoms, supporting the need of future clinical and experimental
studies to clarify the pathophysiological mechanisms underlying the
development of anosmia in COVID-19.
Funding : FRMH Funding.
Conflict of interest statement : The authors have no conflicts
of interest
Acknowledgments: -.